Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Recent advance on viral hepatitis A.

Shou-Dong Lee¹

¹Department of Medicine, Taipei Veterans General Hospital and National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC. sdlee@vghtpe.gov.tw

Journal of the Chinese Medical Association : JCMA

|August 2, 2003

Summary

Hepatitis A virus (HAV) infection, typically fecal-oral, can be severe, especially in older adults or those with chronic liver disease. Vaccination offers a safe and effective way to prevent HAV outbreaks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nucleos(t)ide analogues potentially activate T lymphocytes through inducing interferon expression in hepatic cells and patients with chronic hepatitis B.

Scientific reports·2024

Same author

Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients.

Journal of the Chinese Medical Association : JCMA·2024

Same author

Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response.

Journal of the Chinese Medical Association : JCMA·2023

Same author

Corrigendum to "Investigation of Hepatoprotective Activity of Induced Pluripotent Stem Cells in the Mouse Model of Liver Injury".

BioMed research international·2022

Same author

Fibroblast Growth Factor 19 and Fibroblast Growth Factor 21 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Gastric Bypass.

Nutrients·2022

Same author

Sofosbuvir-based antiviral therapy provided highly treatment efficacy, safety, and good tolerability for Taiwanese chronic hepatitis C patients with decompensated cirrhosis.

Journal of the Chinese Medical Association : JCMA·2021

Area of Science:

Hepatology
Virology
Epidemiology

Background:

Hepatitis A virus (HAV) is a globally prevalent pathogen transmitted via the fecal-oral route.
While most uncomplicated cases resolve within six months, mortality is age-dependent, with higher risks in older individuals and those with chronic hepatitis B or C.
Improved public health has decreased childhood incidence, potentially increasing susceptibility in antibody-naive adult populations, raising concerns for widespread outbreaks.

Purpose of the Study:

To review the epidemiology and clinical significance of Hepatitis A virus (HAV) infection.
To evaluate the role of vaccination in preventing HAV outbreaks.
To highlight the importance of immunization strategies for at-risk populations.

Main Methods:

Literature review of HAV epidemiology, transmission, and clinical outcomes.
Analysis of age-dependent mortality patterns and risk factors for severe disease.
Assessment of the safety and immunogenicity of commercially available inactivated HAV vaccines.

Main Results:

HAV infection mortality is significantly influenced by age and pre-existing liver conditions (Hepatitis B or C).
Reduced incidence in younger populations has led to a larger susceptible adult cohort.
Clinical trials demonstrate that inactivated HAV vaccines are safe and immunogenic across diverse age and risk groups.

Conclusions:

The potential for large-scale Hepatitis A outbreaks necessitates proactive public health interventions.
Immunization is a critical strategy for controlling HAV infection, particularly among vulnerable populations.
Widespread vaccination programs are essential for preventing severe disease and managing the public health impact of Hepatitis A.

Related Experiment Videos